Mersana Therapeutics buy Wedbush
Start price
11.01.25
/
50%
€0.70
Target price
11.01.26
€3.90
Performance (%)
-62.70%
End price
02:15
-
Summary
This prediction is currently being closed. The BUY prediction by Wedbush for Mersana Therapeutics is performing very badly with a performance of -62.70%. Wedbush has a follow-up prediction for Mersana Therapeutics where he still thinks Mersana Therapeutics is a Buy. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Mersana Therapeutics | - | - | - |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% |
Comments by Wedbush for this prediction
In the thread Mersana Therapeutics diskutieren
Mersana Therapeutics, Inc. (NASDAQ: MRSN) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $4.00 price target on the stock, down previously from $7.00.
Ratings data for MRSN provided by MarketBeat
In the thread Trading Mersana Therapeutics
Die von Wedbush gewählte maximale Laufzeit wurde überschritten
Current prediction by Wedbush for Mersana Therapeutics
Mersana Therapeutics
Start price
Target price
Perf. (%)
€0.47
03.03.25
03.03.25
€3.81
03.03.26
03.03.26
-44.40%
25.07.25
25.07.25
Stopped prediction by Wedbush for Mersana Therapeutics
Mersana Therapeutics
Start price
Target price
Perf. (%)
€0.28
15.05.25
15.05.25
€2.68
15.05.26
15.05.26
-7.18%
25.07.25
25.07.25
Mersana Therapeutics
Start price
Target price
Perf. (%)
€0.28
06.05.25
06.05.25
€2.66
06.05.26
06.05.26
-5.30%
25.07.25
25.07.25